Lipoprotein(a) Is the Best Single Marker in Assessing Unstable Angina Pectoris

Table 7

The results of ROC curves analysis of atherogenic indexes in patients with ischemic heart disease.

		AUC	SE	95%CI	Specificity	Sensitivity	Criterion
SAP	apoB/apoA^b	0.717	0.062	0.594–0.820	78.2	64.1	>0.93
	LDL-c/apoB^d	0.771	0.062	0.652–0.865	52.7	76.9	≥3.14
	LDL-c/HDL-c	0.657	0.067	0.531–0.769	65.5	86.2	>3.24
	Tc/HDL-c^d	0.737	0.060	0.615–0.837	63.6	74.3	>5.08
	TG/apoB^a,c	0.897	0.037	0.798–0.958	80.0	54.3	>1.19
	TG/HDL-c^d,e	0.883	0.040	0.781–0.949	87.0	55.9	>0.88
USAP	apoB/apoA^∗∗	0.896	0.034	0.807–0.953	56.8	82.1	>1.08
	LDL-c/apoB	0.745	0.063	0.635–0.836	68.2	76.9	>3.14
	LDL-c/HDL-c	0.840	0.043	0.741–0.912	53.3	93.1	>3.40
	Tc/HDL-c^∗∗	0.873	0.038	0.780–0.937	73.3	71.4	>4.97
	TG/apoB	0.787	0.050	0.681–0.871	61.4	97.1	>1.85
	TG/HDL-c*	0.896	0.034	0.808–0.953	80.0	82.4	>1.54
STEMI	apoB/apoA^A,C	0.879	0.040	0.778–0.945	81.0	41.0	>0.74
	LDL-c/apoB	0.784	0.061	0.668–0.874	76.2	59.0	≤3.33
	LDL-c/HDL-c	0.800	0.052	0.686–0.887	36.4	100.0	>3.76
	Tc/HDL-c^B	0.889	0.038	0.790–0.952	45.5	77.1	>5.22
	TG/apoB	0.849	0.045	0.742–0.923	78.6	74.3	>1.49
	TG/HDL-c^A,D	0.912	0.034	0.819–0.960	88.6	55.9	>0.88

^a𝑃<.05 versus apoB/apoA, LDL-c/apoB and Tc/HDL-c, ^b𝑃<.01 versus LDL-c/HDL-c, ^c𝑃<.01 versus LDL-c/HDL-c, ^d𝑃<.001 versus LDL-c/HDL-c, ^e𝑃<.001 versus Tc/HDL-c, ^∗𝑃<.05 versus LDL-c/apoB and LDL-c/HDL-c, ^∗∗𝑃<.05 versus LDL-c/HDL-c,^A𝑃<.05 versus LDL-c/apoB, ^B𝑃<.05 versus LDL-c/HDL-c, ^C𝑃<.01 versus LDL-c/HDL-c, ^D𝑃<.01 versus TG/apoB.